Order results by:
| Issue | Title | |
| Vol 13, No 2 (2021) | Psychometric properties of the Russian version of the Perth Emotional Reactivity Scale-Short Form | Abstract similar documents |
| P. M. Larionov, E. K. Ageenkova, T. V. Belashina | ||
| "... =0.894; TLI=0.875; RMSEA=0.074 (90% CI 0.062–0.086); SRMR=0.092]. The reliability of the PERS-S ..." | ||
| Vol 9, No 3 (2017) | Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova | ||
| "... number of NMS per patient with PD was 9.13±4.81 in the study group and 5.43±3.4 in the control group (p<0 ..." | ||
| Vol 13, No 3 (2021) | Validation of a Russian version of the Berg Balance Scale | Abstract similar documents |
| N. A. Suponeva, D. G. Yusupova, A. A. Zimin, A. B. Zaitsev, K. A. Yatsko, D. A. Melchenko, A. A. Rimkevichus, E. S. Zhirova, A. S. Taratukhina, A. S. Rizvanova, G. A. Gatina, M. E. Kalinkina, M. A. Piradov, K. Berg | ||
| "... Цель исследования – лингвокультурная адаптация оригинальной версии Шкалы баланса Берг (ШББ; Berg ..." | ||
| Vol 9, No 3 (2017) | Capabilities of perfusion ASPECTS in predicting the efficiency of intravenous thrombolytic therapy | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, V. E. Drobakha, N. A. Kaileva, L. I. Syromyatnikova, Yu. A. Golosova, V. V. Shestakov | ||
| "... (MTT) в 10 зонах мозга в соответствии со шкалой ASPECTS (Alberta Score Program Early CT Score ..." | ||
| Vol 16, No 1 (2024) | A five-point scale for assessing the quality of life of patients with epilepsy | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, A. O. Khabibova, A. M. Azhigova, V. A. Kharkovsky | ||
| "... , порой значительного, времени на их заполнение и последующую обработку. Пятибалльная шкала оценки КЖ у ..." | ||
| Vol 13, No 4 (2021) | IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy | Abstract similar documents |
| A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko | ||
| "... 40 до 100 ЕД (min 1,3, max 4,5 ЕД/кг массы тела). Для оценки эффективности лечения применяли Шкалу ..." | ||
| Vol 15 (2023): (Suppl. 1) | Distinctive parameters of gait in patients with multiple sclerosis, depending on the profile of its dysfunction | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| Vol 16, No 4 (2024) | Validation of the Russian version of Swiss Narcolepsy Scale for narcolepsy type 1 screening | Abstract similar documents |
| A. O. Golovatyuk, A. S. Kuts, A. Yu. Melnikov, A. V. Zaharov, M. G. Poluektov, C. Bassetti | ||
| "... нарколепсии является Шкала нарколепсии Улланлинны (ШНУ; Ullanlinna Narcolepsy Scale), обладающая высокой ..." | ||
| Vol 10, No 4 (2018) | Validation of the modified Rankin Scale in Russia | Abstract similar documents |
| N. A. Suponeva, D. G. Yusupova, E. S. Zhirova, D. A. Melchenko, A. S. Taratukhina, А. A. Butkovskaya, K. A. Ilyina, A. B. Zaitsev, A. A. Zimin, A. S. Klochkov, R. Kh. Lyukmanov, M. E. Kalinkina, M. А. Piradov, A. M. Kotov-Smolensky, A. E. Khizhnikova | ||
| "... Цель — создание русскоязычной версии модифицированной шкалы Рэнкина (МШР) и оценка ее ..." | ||
| Vol 4, No 1 (2012) | Use of Addenbrooke’s cognitive examination-revised to evaluate the patients’ state in general medical practice | Abstract similar documents |
| Nikolai Nikolayevich Ivanets, D M Tsarenko, M A Bobrova, A A Kursakov, E G Starostina, A E Bobrov | ||
| "... таких больных модифицированной Адденбрукской когнитивной шкалы «Addenbrooke's Cognitive Examination ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Cognitive and emotional changes in patients with juvenile myoclonic epilepsy | Abstract similar documents |
| R. V. Magzhanov, D. V. Anisimova, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsivadze, S. R. Nurmukhametova | ||
| "... Монреальской шкале оценки когнитивных функций выявлено у 12 (40%) пациенток. Наибольшие трудности пациентки ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Polymorphic variants in the PVT1 locus affect multiple sclerosis severity | Abstract PDF (Eng) similar documents |
| I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... прогрессирующей неврологической дисфункцией. Для определения тяжести течения РС по существующим шкалам требуется ..." | ||
| Vol 11, No 4 (2019) | Prognostic significance of moderate cognitive impairment in patients at high and very high cardiovascular risk | Abstract similar documents |
| V. V. Henkel, A. S. Kuznetsova, A. O. Salashenko, E. V. Lebedev, I. I. Shaposhnik | ||
| "... помощью краткой шкалы оценки психического статуса (КШОПС), у пациентов с высоким и очень высоким ..." | ||
| Vol 11, No 3 (2019) | Back pain and osteoporosis | Abstract similar documents |
| A. I. Isaikin, O. Yu. Isaikina, T. I. Shadyzheva, Yu. M. Shor, M. S. Kachanovsky | ||
| "... М.А. Katbleen. Интенсивность боли определяли по числовой рейтинговой шкале, наличие невропатического ..." | ||
| Online-first | Прогностическая значимость умеренных когнитивных нарушений у пациентов с высоким и очень высоким кардиоваскулярным риском | Abstract similar documents |
| В. В. Генкель, А. С. Кузнецова, А. О. Салашенко, Е. В. Лебедев, И. И. Шапошник | ||
| "... помощью краткой шкалы оценки психического статуса (КШОПС), у пациентов с высоким и очень высоким ..." | ||
| Vol 8, No 1 (2016) | Multiple sclerosis-related fatigue and possibilities of its correction | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... тесты и шкалы. Наиболее распространены шкала Fatigue Severity Scores (FSS) для оценки физической и ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... recieved omberacetam 10 mg 2 times per day, the 2nd group – piracetam/cinnarizine 400/25 mg (1 tablet) 3 ..." | ||
| Vol 16, No 3 (2024) | Observational study of the effect of perampanel on sleep and daytime sleepiness in adult patients with epilepsy in real-life clinical practice | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, M. A. Vagina, A. V. Vasilenko, T. M. Goguadze, T. V. Danilova, O. N. Kirillovskikh, I. Yu. Kovaleva, Yu. A. Kornukova, S. Yu. Lavrik, I. V. Larina, L. V. Lipatova, E. R. Tokareva, A. V. Ulitin, N. V. Filatova, M. A. Yamin | ||
| "... on the effect of perampanel (PER) on sleep emphasise the positive effect of the drug on sleep quality, daytime ..." | ||
| Vol 14, No 1 (2022) | Validation of the Russian version of Stress and Anxiety to Viral Epidemics – 9 items (SAVE-9) among healthcare workers during COVID-19 pandemic | Abstract similar documents |
| E. S. Mosolova, S. Chung, D. N. Sosin, S. N. Mosolov | ||
| "... стресса и тревоги в условиях эпидемии. Цель исследования – валидация русскоязычной версии шкалы «Стресс и ..." | ||
| Vol 6, No 3 (2014) | The risk factors and prevention of stroke in atrial fibrillation | Abstract similar documents |
| V. A. Parfenov, S. V. Verbitskaya | ||
| "... проанализированы ФР инсульта при ФП. Отмечается информативность простой в использовании шкалы CHA2DS2-VASc ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... =0.876), asthenia 89.6±1.1 points on the MFI-20 scale with an increase of 1.48% per year (Beta=0 ..." | ||
| Vol 8, No 4 (2016) | USE OF AN INFRA-LOW FREQUENCY EEG BIOLOGICAL FEEDBACK TECHNIQUE IN THE COMPREHENSIVE REHABILITATION OF PATIENTS WITH A DECREASED LEVEL OF CONSCIOUSNESS | Abstract similar documents |
| M. V. Shendyapina, S. A. Kazymaev, T. V. Shapovalenko, K. V. Lyadov | ||
| "... and every 3 weeks during BFB therapy (5 BFB sessions per week). Results. According ..." | ||
| Vol 10, No 2 (2018) | Interventional medicine techniques in the treatment of nonspecific low back pain caused by sacroiliac joint dysfunction | Abstract similar documents |
| A. V. Kavelina, A. I. Isaikin, M. A. Ivanova | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... coefficient R=-0.41) between the number of headache (HA) days per month and the MoCA score (p<0 ..." | ||
| Vol 16, No 3 (2024) | Analyzing the predictors of relapse in drug-induced headache: a prospective clinical and psychological study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... of analgesic use per day (OR 15.8; 95% C113.1—23.4), degree of alexithymia (score on TAS-26 scale: OR 11.3; 95 ..." | ||
| Vol 16, No 1 (2024) | Safety and efficacy of fremanezumab in real clinical practice in patients with chronic migraine | Abstract similar documents |
| G. N. Belskaya, A. V. Krasnikov, E. A. Kiryanova, M. E. Prokopovich, E. V. Sakharova, G. V. Makarov | ||
| "... intensity using a visual analogue scale (VAS), a reduction in the number of headache days per month by 50 ..." | ||
| Vol 14, No 3 (2022) | The efficacy of ipidacrine in patients with diabetic polyneuropathy | Abstract similar documents |
| P. R. Kamchatnov, E. R. Barantsevich, A. V. Chugunov, A. A. Kabanov, B. A. Abusueva | ||
| "... ipidacrine 15 mg 1 time per day intramuscularly for 15 days, then – 20 mg 3 times a day orally up to 2 months ..." | ||
| Vol 16, No 1 (2024) | Treatment of cognitive impairment in patients with cerebral infarction in the internal carotid arteries circulation system: results of a multicentre, randomized, double-blind, placebo-controlled clinical trial | Abstract similar documents |
| D. R. Khasanova, A. A. Yakupova, P. R. Kamchatnov, Zh. Yu. Chefranova, E. I. Bogdanov, P. I Pilipenko, N. M. Khasanova | ||
| "... included in the study). The results of the per-protocol (PP) analysis are shown in square brackets ..." | ||
| Vol 8, No 3 (2016) | Epidemiology of multiple sclerosis in the Bryansk Region | Abstract similar documents |
| Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina | ||
| "... : the prevalence of the disease is 48.1 cases per 100,000; its incidence in the individual districts of the region ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Clinical and psychoemotional characteristics of patients with medication overuse headache | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... associated with an increase in the number of days with headache (HA) by 0.33 days per month. In addition ..." | ||
| Vol 2, No 4 (2010) | Pediatric Tenoten in therapy of childhood nocturnal enuresis | Abstract similar documents |
| G. M. Dzhanumova, A. V. Budkevich, L. B. Ivanov | ||
| "... of nocturnal enuresis episodes per month and anxiety scale scores). Results. There was a significant reduction ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... per treatment cycle were as follows: Dysport was 400 to 1000 U, xeomin was 50 to 300 U, and Botox 200 ..." | ||
| Vol 13, No 6 (2021) | Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute non-specific lower back pain | Abstract similar documents |
| V. A. Parfenov, E. I. Bogdanov, V. B. Laskov, N. S. Makarov, N. V. Pisova, E. A. Salina, Zh. Yu. Chefranova, L. V. Chichanovskaya | ||
| "... for patients, since it reduces the frequency of drug administration per day: from three immediate release ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... tablet three times per day). Patients with CI (mean MoCA score ≤25 points; n=50) were prescribed ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... short courses (up to 10 days per year) to achieve a long-term effect on the immune system. The dose ..." | ||
| Vol 15, No 2 (2023) | Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis | Abstract similar documents |
| I. A. Gribacheva, T. F. Popova, E. V. Petrova, A. V. Zvonkova | ||
| "... by drip infusion (500 mg 1 time per day) for 14 days, followed by oral administration of the drug Mexidol ..." | ||
| Vol 14, No 5 (2022) | Results of ELBRUS clinical non-interventional study | Abstract similar documents |
| D. O. Rozhkov, K. V. Shevtsova, V. V. Grinyuk, V. A. Parfenov | ||
| "... ) was conducted to investigate the efficacy and safety of daily administration of Rixia® (Etoricoxib) 60 mg per ..." | ||
| Vol 15, No 1 (2023) | Association of sleep disorders with various polymorphic variants of the 5-HTTLPR SNP rs25531 A>G gene in people aged 25–44 | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, I. V. Gagulin, D. O. Panov, V. N. Maksimov, M. A. Gubina, A. V. Gafarova | ||
| "... =11.397; df=4; p<0.05). In 19.6% of men and 21.5% of women, sleep duration was 6 hours per day, 5 ..." | ||
| Vol 13, No 2 (2021) | Pain reliever combinations in treatment of patients with acute musculoskeletal back pain | Abstract similar documents |
| R. V. Gorenkov, M. N. Dadasheva, D. I. Lebedeva, I. V. Choi | ||
| "... Russian drugs meloxicam (Amelotex 15 mg per day), tolperison (Kalmirex), and a neurotropic multivitamin ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... before the start of treatment was 1.2 per year; after treatment with cladribine tablets it was 0.05 per ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... шкале Хен–Яра). Все больные в течение 8 мес получали лечение вортиоксетином в дозе 15 или 20 мг/сут ..." | ||
| Vol 17, No 1 (2025) | Analysis of the migraine characteristics in the perimenopause | Abstract similar documents |
| D. A. Klimentova, G. R. Tabeeva | ||
| "... of days with headache per month are significantly higher in perimenopause than in RA (p<0.05). The risk ..." | ||
| Vol 3, No 3 (2011) | Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) | Abstract similar documents |
| M. R. Nodel | ||
| "... унифицированной шкалы оценки БП, шкалы оценки двигательных флюктуаций, опросника депрессии Бека, шкалы оценки ..." | ||
| Vol 12, No 6 (2020) | The use of perampanel in drug-resistant focal epilepsy: its effect on sleep | Abstract similar documents |
| A. A. Filin, M. V. Tardov, N. L. Kunelskaya, P. N. Vlasov | ||
| "... Perampanel (PER) is an antiepileptic drug (AED), the effects of which on sleep have not been ..." | ||
| Vol 12, No 3 (2020) | Features of the pathogenesis, diagnosis, and treatment of panic attacks in young people | Abstract similar documents |
| M. L. Chukhlovina | ||
| "... шкалу тяжести панического расстройства, для выявления тревожного состояния — шкалу тревоги Кови. С целью ..." | ||
| Vol 11, No 1 (2019) | Efficiency of long-term vinpocetine administration in the treatment of dizziness and associated statodynamic disorders in patients with chronic cerebrovascular insufficiency (EDELWEISS study) | Abstract similar documents |
| I. N. Samartsev, S. A. Zhivolupov, Yu. S. Butakova, M. V. Morozova, I. N. Barsukov | ||
| "... шкалы головокружения (ВАШ-Г), шкалы влияния головокружения на повседневную активность (Dizziness ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Rehabilitation of patients with progressive forms of multiple sclerosis | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofyeva, A. V. Zotova, A. A. Belkin, M. A. Sherman | ||
| "... . Состояние всех пациентов было оценено по валидированным шкалам: Опросник Бека, суицидальная шкала, Опросник ..." | ||
| Vol 14, No 1 (2022) | Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... full treatment courses. HAMS diagnosis was established in the presence of two or more exacerbations per ..." | ||
| Vol 12, No 1 (2020) | The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia | Abstract similar documents |
| V. V. Burdakov, D. V. Krasnykh | ||
| "... динамике изучали субъективные жалобы, неврологическую симптоматику, показатели шкалы Тинетти для оценки ..." | ||
| Vol 11, No 1 (2019) | Primary progressive aphasia | Abstract PDF (Eng) similar documents |
| V. A. Mikhailov, Yu. V. Kotsiubinskaya, N. Yu. Safonova, N. I. Ananieva, I. K. Stulov | ||
| "... нейровизуализационные характеристики разных видов ППА. Предлагаемая балльная шкала тяжести симптомов ППА позволяет ..." | ||
| No 1S (2016): | Russian experience with perampanel in routine clinical practice | Abstract similar documents |
| V. A. Karlov, O. V. Belyaev, P. N. Vlasov, I. A. Zhidkova, I. V. Volkov, D. V. Dmitrenko, A. Yu. Karas, T. V. Kazennykh, O. I. Miguskina, A. V. Moskvicheva, E. N. Paramonova, I. V. Ponomareva, A. V. Chervyakov | ||
| "... Objective: to generalize the Russian experience with perampanel (PER) in routine clinical practice ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Possibilities to optimize pharmacotherapy for epilepsy according to the data of an epidemiological survey in Sterlitamak | Abstract similar documents |
| S. R. Nurmukhametova, R. V. Magzhanov | ||
| "... patients. This yielded prevalence and incidence rates for epilepsy in Sterlitamak (2.74 per 1000 population ..." | ||
| Vol 13, No 1 (2021) | Evaluation of the efficacy and tolerability of naftidrofuryl in the therapy of chronic cerebral ischemia | Abstract similar documents |
| M. N. Dadasheva, I. A. Zolotovskaya, R. V. Gorenkov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... и эмоционального состояния пациентов использовали следующие тесты и шкалы: тест Mini-cog, Краткую ..." | ||
| Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
| V. V. Kovalchuk | ||
| "... , их состояние оценивалось по выраженности клинических проявлений ХИГМ с помощью специальных шкал и ..." | ||
| Vol 7, No 2 (2015) | The symptoms of pathological fatigue, apathy, and depression in patients after stroke | Abstract similar documents |
| M. A. Kutlubaev, L. R. Akhmadeeva | ||
| "... усталости, апатии и депрессии использовали шкалу оценки усталости, шкалу оценки апатии и подшкалу депрессии ..." | ||
| Vol 17, No 3 (2025) | Autonomic cardiovascular dysregulation and other non-motor manifestations of Parkinson’s disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov | ||
| "... ), ортостатическая проба, также использовались Унифицированная рейтинговая шкала болезни Паркинсона (Unified ..." | ||
| Vol 15, No 5 (2023) | Efficacy and safety of Vespireit® (buspirone) prolonged-release tablets (PR) 15 mg in the therapy of patients with functional dizziness: results of the double-blind, placebo-controlled, multicenter, randomized, phase 3 clinical trial | Abstract similar documents |
| M. V. Zamergrad, V. A. Parfenov, A. S. Agafina, N. V. Lyamina, M. M. Gavrik, L. R. Kuchumova, E. R. Barantsevich, V. S. Krasnov, A. A. Ivanova, A. L. Vladykin, K. А. Ishchenko | ||
| "... дисфункции, сопровождающимся ФГ и баллом по Шкале оценки головокружения (The Dizziness Handicap Inventory ..." | ||
| Vol 12, No 1 (2020) | Experience with vortioxetine in the treatment of post-stroke depression | Abstract similar documents |
| I. A. Strelnikova, A. A. Svetkina, Yu. D. Minina, O. V. Androfagina | ||
| "... бассейне с симптомами легкой и умеренной депрессии по шкале депрессии Монтгомери–Асберга (Montgomery–Asberg ..." | ||
| Vol 16, No 3 (2024) | Clinical and neurophysiological features of the augmentation phenomenon in restless legs syndrome | Abstract similar documents |
| N. A. Gorbachev, A. V. Obukhova, L. A. Fedeneva, M. G. Poluektov | ||
| "... . Производилась клиническая оценка при помощи рейтинговой шкалы оценки тяжести СБН (РШ), Монреальской шкалы оценки ..." | ||
| Vol 16, No 4 (2024) | Kinesiotherapy in painful diabetic polyneuropathy | Abstract similar documents |
| E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova | ||
| "... комплекса упражнений. Оценка характера невропатической боли проводилась с помощью Шкалы общей оценки ..." | ||
| Vol 12, No 3 (2020) | A Russian retrospective multicenter open-label observational study based on medical documentation on the use of perampanel in everyday clinical practice | Abstract PDF (Eng) similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, D. V. Dmitrenko, I. G. Rudakova, T. V. Danilova, V. A. Kalinin, O. V. Grebenyuk, A. P. Gertsen, Ya. S. Zhuravlev, A. Yu. Karas, E. N. Paramonova, I. V. Ponomareva, O. I. Miguskina, N. A. Sobyanina, D. V. Sukhova, Yu. V. Salomatin, M. L. Ertakhova, T. M. Goguadze, A. P. Shamray | ||
| "... Objective: to retrospectively assess the Russian experience with perampanel (PER) in everyday ..." | ||
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... памяти и других когнитивных функций. Когнитивный статус оценивался по Краткой шкале оценки психического ..." | ||
| Vol 6, No 2 (2014) | Experience with non-drug therapies (psychotherapy, phytotherapy, reflexotherapy) for neurasthenia | Abstract similar documents |
| S.A Bozhko, N.A. Tyuvina | ||
| "... методами с использованием психометрических тестов: шкалы общего клинического впечатления (CGI), теста ..." | ||
| Vol 3, No 4 (2011) | Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole | Abstract similar documents |
| M. R. Nodel | ||
| "... (длительность болезни – 6,02±3,47 года, стадия – 2,68±0,62) без деменции. Применялись шкала утомляемости при БП ..." | ||
| Vol 8, No 4 (2016) | AFFECTIVE DISORDERS IN MYASTHENIA | Abstract similar documents |
| D. Yu. Konkova, V. N. Karnaukh | ||
| "... депрессии по шкале Цунга. Уточняли связь этих показателей с полом, возрастом, длительностью, степенью ..." | ||
| Vol 14, No 1 (2022) | The efficacy and safety of ipidacrine in patients with idiopathic neuropathy of the facial nerve (PELICAN study) | Abstract similar documents |
| I. N. Samartsev, S. A. Zhivolupov, V. V. Ponomarev, M. N. Markova, K. R. Magomedov | ||
| "... длительность периода наблюдения составила 6 мес. Оценка эффективности терапии проводилась с помощью шкал House ..." | ||
| Vol 12, No 3 (2020) | Arm spasticity after stroke: botulinum toxin therapy in combination with multimodal stimulation | Abstract similar documents |
| V. N. Lutsik, E. V. Slyunkova, S. V. Kotov, V. K. Misikov, E. V. Biryukova | ||
| "... использования БТА. Неврологический дефицит оценивали до и после лечения по шкалам Эшворта (mAS), Fugl—Meyer (FM ..." | ||
| Vol 13, No 2 (2021) | Depression, anxiety and motivation in arterial hypertension | Abstract similar documents |
| S. K. Mezhmidinova, V. V. Zakharov, N. V. Vakhnina | ||
| "... ). Нейропсихологический статус пациентов определяли с помощью Краткой шкалы оценки психического статуса, Монреальской ..." | ||
| Vol 10, No 1 (2018) | A relationship between the integrated assessment of magnetic resonance imaging markers for cerebral small vessel disease and the clinical and functional status in the acute period of ischemic stroke | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, N. A. Kaileva, N. Kh. Gorst, V. V. Shestakov | ||
| "... . Общепринятой магнитно-резонансной (МР) шкалы для интегральной оценки маркеров ЦБМС не существует. Цель ..." | ||
| 1 - 70 of 341 Items | 1 2 3 4 5 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
